Works matching IS 2160763X AND DT 2014 AND VI 3 AND IP 4

Results: 13

Rivaroxaban crushed tablet suspension characteristics and relative bioavailability in healthy adults when administered orally or via nasogastric tube.

Published in:

Clinical Pharmacology in Drug Development, 2014, v. 3, n. 4, p. 321, doi. 10.1002/cpdd.123

By:

Moore, Kenneth T.;
Krook, Mark A.;
Vaidyanathan, Seema;
Sarich, Troy C.;
Damaraju, C. V.;
Fields, Larry E.

Publication type:

Article

Population pharmacokinetic analysis of dutogliptin, a selective dipeptidyl peptidase-4 inhibitor.

Published in:

Clinical Pharmacology in Drug Development, 2014, v. 3, n. 4, p. 297, doi. 10.1002/cpdd.87

By:

Marier, Jean‐Francois;
Mouksassi, Mohamad‐Samer;
Gosselin, Nathalie H.;
Li, Jianke

Publication type:

Article

Pharmacokinetics and pharmacodynamics of guanfacine extended release in adolescents aged 13-17 years with attention-deficit/hyperactivity disorder.

Published in:

Clinical Pharmacology in Drug Development, 2014, v. 3, n. 4, p. 252, doi. 10.1002/cpdd.124

By:

Martin, Patrick;
Satin, Lawrence;
Vince, Bradley D.;
Padilla, Americo F.;
White, Carla;
Corcoran, Mary;
Stevenson, Annette;
Ermer, James

Publication type:

Article

A food effect study and dose proportionality study to assess the pharmacokinetics and safety of bardoxolone methyl in healthy volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2014, v. 3, n. 4, p. 314, doi. 10.1002/cpdd.74

By:

Teuscher, Nathan S.;
Kelley, Richard J.;
Dumas, Emily O.;
Klein, Cheri Enders;
Awni, Walid M.;
Meyer, Colin J.

Publication type:

Article

Issue Information.

Published in:: Clinical Pharmacology in Drug Development, 2014, v. 3, n. 4, p. i, doi. 10.1002/cpdd.67
Publication type:: Article

Pharmacokinetics and safety of teneligliptin in subjects with hepatic impairment.

Published in:

Clinical Pharmacology in Drug Development, 2014, v. 3, n. 4, p. 290, doi. 10.1002/cpdd.89

By:

Halabi, Atef;
Maatouk, Haidar;
Siegler, Karl Ernst;
Faisst, Nadja;
Hinrichsen, Holger

Publication type:

Article

Drug interactions with methadone: Time to revise the product label.

Published in:

2014

By:

Greenblatt, David J.

Publication type:

Editorial

A semi-mechanistic model to characterize the pharmacokinetics and pharmacodynamics of brodalumab in healthy volunteers and subjects with psoriasis in a first-in-human single ascending dose study.

Published in:

Clinical Pharmacology in Drug Development, 2014, v. 3, n. 4, p. 276, doi. 10.1002/cpdd.103

By:

Salinger, David H.;
Endres, Christopher J.;
Martin, David A.;
Gibbs, Megan A.

Publication type:

Article

A double-blind, randomized, ascending, multiple-dose study of bazedoxifene in healthy postmenopausal women.

Published in:

Clinical Pharmacology in Drug Development, 2014, v. 3, n. 4, p. 262, doi. 10.1002/cpdd.102

By:

McKeand, William E.;
Orczyk, Gayle P.;
Ermer, James C.;
Chines, Arkadi A.

Publication type:

Article

A Phase I cardiac safety and pharmacokinetic study of tivozanib hydrochloride in patients with advanced solid tumors.

Published in:

Clinical Pharmacology in Drug Development, 2014, v. 3, n. 4, p. 284, doi. 10.1002/cpdd.113

By:

Moore, Kathleen;
Infante, Jeffrey R.;
Cotreau, Monette M.;
Wilson, Lindsey;
Strahs, Andrew L.;
Vargo, Dennis L.;
Chadha, Manpreet

Publication type:

Article

Evaluation of the pharmacokinetics and pharmacodynamics of two leuprolide acetate 45 mg 6-month depot formulations in patients with prostate cancer.

Published in:

Clinical Pharmacology in Drug Development, 2014, v. 3, n. 4, p. 270, doi. 10.1002/cpdd.112

By:

Mostafa, Nael M.;
Chwalisz, Kristof;
Larsen, Lois;
Mattia‐Goldberg, Cynthia;
Spitz, Aaron;
Pradhan, Rajendra S.

Publication type:

Article

A phase 1, randomized study to assess the pharmacokinetic comparability of siltuximab derived from two different cell lines in healthy subjects.

Published in:

Clinical Pharmacology in Drug Development, 2014, v. 3, n. 4, p. 328, doi. 10.1002/cpdd.86

By:

Xu, Chao;
Han, Chao;
Marini, Joseph;
Ford, Joyce;
Marciniak, Stanley;
Lopez, Manny;
Frederick, Bart;
de Vries, Dick;
Bandekar, Rajesh;
Davis, Hugh M.;
Zhou, Honghui;
Puchalski, Thomas A.

Publication type:

Article

Pharmacokinetics and pharmacodynamics of GSK961081, a novel inhaled muscarinic antagonist β<sub>2</sub>-agonist, and fluticasone propionate administered alone, concurrently and as a combination blend formulation in healthy volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2014, v. 3, n. 4, p. 305, doi. 10.1002/cpdd.105

By:

Norris, Virginia;
Ambery, Claire;
Riley, Trevor

Publication type:

Article